Tag Archives: Another

ADA: Novo Nordisk’s oral semaglutide posts another heart safety win

SAN FRANCISCO—Novo Nordisk may have already submitted its approval application for its oral GLP-1 drug semaglutide, but the deluge of positive data hasn’t stopped. Tuesday at the American Diabetes Association annual meeting, the Danish drugmaker rolled out cardiovascular outcomes results showing that the its wannabe blockbuster didn’t hurt cardiovascular safety in high-risk Type 2 diabetes… Read More »

‘God was there’: A year after landmark Canadian transplant, Maurice Desjardins is learning to live with another man’s face

“Gun cleaner shoots self” — Ottawa Sun headline, Jan. 12, 2011NOTRE-DAME-DE-LA-SALETTE, Que. — On the mantel inside the Desjardins house, which hugs Lac de l’Argile, a mountain lake about an hour’s drive northeast of Ottawa, there are no framed photos of Maurice Desjardins taken after what the family calls only “the accident.” There’s a picture… Read More »

Bayer asks California judge to limit evidence in another Roundup cancer trial

(Reuters) – Bayer AG unit Monsanto has asked a California judge in the litigation over its glyphosate-based weed killer Roundup allegedly causing cancer to limit evidence by splitting an upcoming trial into two phases, a request previously successful with another judge. FILE PHOTO: The logo of Bayer AG, February 24, 2014. REUTERS/Ina Fassbender/File Photo Monsanto… Read More »